NCT06995976
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
StatusCompleted
PhaseEarly Phase 1
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Trial completed
- Final enrollment: 15 participants (planned 30)
- Secondary endpoints: details revised at 1 of 1 entry
- Site details revised
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
SUV of tumors
Timeframe: Through study completion, an average of 3 months
Secondary (1)
Diagnostic value
Arms and interventions
68Ga-dPNE PET/CTExperimental
Intravenous injection of 68Ga-dPNE. 68Ga-dPNE PET/CT will be used to detect tumors.
18F-FDG PET/CTExperimental
Intravenous injection of 18F-FDG. 18F-FDG PET/CT will be used to detect tumors.
Drugs: 68Ga-dPNE, 18F-FDG
Sites
1 site in 1 country
- The First Affiliated Hospital of Fujian Medical UniversityFuzhou, Fujian, China